RESPIRATORY INFECTION
Clinical trials for RESPIRATORY INFECTION explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY INFECTION trials appear
Sign up with your email to follow new studies for RESPIRATORY INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to calm lungs in severe pneumonia
Disease control Recruiting nowThis study is testing a new drug called AV-001 for adults hospitalized with pneumonia from COVID-19 or other infections. The goal is to see if the drug is safe and if it can help patients improve by reducing lung inflammation and damage, potentially helping them breathe better an…
Matched conditions: RESPIRATORY INFECTION
Phase: PHASE2 • Sponsor: Vasomune Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New test aims to spot coronaviruses faster
Diagnosis Recruiting nowThis study is evaluating a new diagnostic test designed to detect multiple coronaviruses, including the one that causes COVID-19. Researchers will use leftover nasal swab samples from about 1,500 people who were tested for a respiratory infection. The main goal is to see how accu…
Matched conditions: RESPIRATORY INFECTION
Sponsor: BioFire Defense LLC • Aim: Diagnosis
Last updated Mar 24, 2026 12:02 UTC
-
New pill aims to stop repeat chest infections before they start
Prevention Recruiting nowThis study is testing if a medication called Buccalin can help prevent recurring lower respiratory tract infections, like bronchitis, in adults who get them often. About 240 participants will take either Buccalin or a placebo pill for 12 months to see which group has fewer infect…
Matched conditions: RESPIRATORY INFECTION
Phase: PHASE4 • Sponsor: Laboratorio Farmaceutico SIT srl • Aim: Prevention
Last updated Apr 01, 2026 14:42 UTC